Ibex Wealth Advisors Buys Shares of 250,041 Healthpeak Properties, Inc. (NYSE:DOC)

Ibex Wealth Advisors bought a new stake in shares of Healthpeak Properties, Inc. (NYSE:DOC) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 250,041 shares of the real estate investment trust’s stock, valued at approximately $5,056,000.

Several other large investors have also recently made changes to their positions in DOC. Mirae Asset Global Investments Co. Ltd. raised its position in shares of Healthpeak Properties by 16.6% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 110,498 shares of the real estate investment trust’s stock worth $2,217,000 after acquiring an additional 15,753 shares in the last quarter. Lightrock Netherlands B.V. bought a new position in shares of Healthpeak Properties in the 4th quarter worth $5,689,000. Armor Investment Advisors LLC raised its position in shares of Healthpeak Properties by 3.5% in the 4th quarter. Armor Investment Advisors LLC now owns 46,619 shares of the real estate investment trust’s stock worth $945,000 after acquiring an additional 1,597 shares in the last quarter. Kentucky Trust Co purchased a new position in Healthpeak Properties during the 4th quarter worth $751,000. Finally, MFG Wealth Management Inc. purchased a new position in Healthpeak Properties during the 4th quarter worth $2,506,000. 93.57% of the stock is owned by institutional investors.

Healthpeak Properties Stock Up 0.0%

Shares of DOC opened at $17.27 on Tuesday. Healthpeak Properties, Inc. has a 52 week low of $16.64 and a 52 week high of $23.26. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.96. The company has a market capitalization of $11.99 billion, a price-to-earnings ratio of 49.33, a PEG ratio of 2.17 and a beta of 1.04. The stock’s 50-day moving average price is $17.81 and its 200-day moving average price is $19.53.

Healthpeak Properties (NYSE:DOC) last released its quarterly earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.46. The company had revenue of $702.89 million during the quarter, compared to analysts’ expectations of $690.76 million. Healthpeak Properties had a return on equity of 2.61% and a net margin of 9.00%. Healthpeak Properties’s quarterly revenue was up 15.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.45 EPS. On average, sell-side analysts predict that Healthpeak Properties, Inc. will post 1.86 EPS for the current year.

Healthpeak Properties Announces Dividend

The firm also recently declared a dividend, which was paid on Friday, May 30th. Investors of record on Tuesday, May 20th were issued a $0.1017 dividend. The ex-dividend date of this dividend was Monday, May 19th. This represents a yield of 7.05%. Healthpeak Properties’s payout ratio is 305.00%.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on DOC. Robert W. Baird dropped their target price on Healthpeak Properties from $24.00 to $22.00 and set an “outperform” rating on the stock in a research note on Tuesday, April 29th. Wall Street Zen downgraded Healthpeak Properties from a “hold” rating to a “sell” rating in a research note on Thursday, May 1st. Wells Fargo & Company dropped their target price on Healthpeak Properties from $22.00 to $20.00 and set an “equal weight” rating on the stock in a research note on Monday, June 2nd. Wedbush dropped their target price on Healthpeak Properties from $24.00 to $22.00 and set an “outperform” rating on the stock in a research note on Monday, April 28th. Finally, Argus restated a “buy” rating and set a $25.00 target price on shares of Healthpeak Properties in a research note on Tuesday, April 29th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat, Healthpeak Properties presently has a consensus rating of “Moderate Buy” and a consensus target price of $23.27.

Insider Buying and Selling

In other news, Director Tommy G. Thompson bought 5,777 shares of Healthpeak Properties stock in a transaction on Wednesday, May 28th. The stock was acquired at an average price of $17.27 per share, with a total value of $99,768.79. Following the completion of the acquisition, the director now directly owns 144,290 shares of the company’s stock, valued at $2,491,888.30. The trade was a 4.17% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director John T. Thomas bought 4,200 shares of Healthpeak Properties stock in a transaction on Monday, April 28th. The shares were purchased at an average cost of $17.84 per share, with a total value of $74,928.00. Following the acquisition, the director now directly owns 813,566 shares of the company’s stock, valued at approximately $14,514,017.44. The trade was a 0.52% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders acquired 29,764 shares of company stock valued at $521,909. 0.23% of the stock is owned by company insiders.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.